SXSW 2022
Beyond Fertility: The FemAging Era in HealthTech
Description:
WHY IS SILICON VALLEY MISSING THE $600 BILLION MIDLIFE WOMEN’S HEALTH CRISIS?
It’s no secret that women over the age of 40 represent a growing, diverse and economically powerful group. However, the unique health, wellness and innovation needs of the over 53 million women in the United States aged 40-60 have largely been ignored by Silicon Valley. Midlife wellness is not niche and this session brings together physicians, investors, innovators and entrepreneurs to discuss, illustrate and explore opportunities and challenges to advance women’s health. Discussion topics include Exploring the Why Behind the Women’s Health Gap; Women’s Health Investors on the FemAging Opportunity and What Does Agile Innovation Look Like in the FemAging Era?
Related Media
Takeaways
- Women’s health is not just about fertility
- Women of color have unique needs when it comes to FemAging Tech innovations
- FemAging Tech innovations don’t just include devices, but innovations in nutrition and clothing
Speakers
- Denise Pines, Co-founder, The FemAging Project
- Chrisandra Shufelt, Associate Director, Barbra Streisand Women’s Heart Center co-Director, Preventive & Rehabilitative Cardiac Center Director, Women’s Hormone and Menopause Program Professor,, Cedars-Sinai Medical Center, Smidt Heart Institute
- Fard Johnmar, Founder, Enspektos
- Alice Zheng, Women's Health Practice Leader, McKinsey & Company, Inc.
Organizer
Denise Pines, Co-founder, FemAging
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments